Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo

PLoS ONE

Volumn 12, Issue 6, 2017, Pages

  Cheng, Sheng Tao ^a   Tang, Hua ^a   Ren, Ji Hua ^a   Chen, Xiang ^b   Huang, Ai Long ^a,c   Chen, Juan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ZHUZHOU CENTRAL HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; HEPATITIS B CORE ANTIGEN; INTERLEUKIN 34; MESSENGER RNA; RECOMBINANT CYTOKINE; RNA; VIRUS DNA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-34, HUMAN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE DOSAGE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS INHIBITION; VIRUS REPLICATION; ADULT; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HEP-G2 CELL LINE; HOST PATHOGEN INTERACTION; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR CELL LINE; VIROLOGY; YOUNG ADULT;

ADULT; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIVER NEOPLASMS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION; YOUNG ADULT;

EID: 85020828996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0179605     Document Type: Article

References (36)

1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212–9. https://doi.org/10.1016/j.vaccine.2011.12.116 PMID: 22273662.
2. Summers J, Mason WS. Replication of the genome of a hepatitis B—like virus by reverse transcription of an RNA intermediate. Cell. 1982; 29(2): 403–15. PMID: 6180831.
3. Locarnini S. Molecular virology of hepatitis B virus. Seminars in liver disease. 2004; 24 Suppl 1: 3–10. https://doi.org/10.1055/s-2004-828672 PMID: 15192795.
4. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012; 3. https://doi.org/10.7554/eLife.00049 PMID: 25409679.
5. Neuveut C, Wei Y, Buendia MA. Mechanisms of HBV-related hepatocarcinogenesis. Journal of hepatology. 2010; 52(4): 594–604. https://doi.org/10.1016/j.jhep.2009.10.033 PMID: 20185200.
6. Dandri M, Petersen J. Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016; 62 Suppl 4: S281–8. https://doi.org/10.1093/cid/ciw023 PMID: 27190317;
7. Pham EA, Perumpail RB, Fram BJ, Glenn JS, Ahmed A, Gish RG. Future Therapy for Hepatitis B Virus: Role of Immunomodulators. Current hepatology reports. 2016; 15(4): 237–44. https://doi.org/10.1007/ s11901-016-0315-9 PMID: 27917363;
8. Garceau V, Smith J, Paton IR, Davey M, Fares MA, Sester DP, et al. Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products. Journal of leukocyte biology. 2010; 87(5): 753–64. https://doi.org/10.1189/jlb.0909624 PMID: 20051473.
9. Wei S, Nandi S, Chitu V, Yeung YG, Yu W, Huang M, et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. Journal of leukocyte biology. 2010; 88(3): 495–505. https://doi.org/10.1189/jlb.1209822 PMID: 20504948;
10. Chen Z, Buki K, Vaaraniemi J, Gu G, Vaananen HK. The critical role of IL-34 in osteoclastogenesis. PloS one. 2011; 6(4): e18689. https://doi.org/10.1371/journal.pone.0018689 PMID: 21494622;
11. Zwicker S, Martinez GL, Bosma M, Gerling M, Clark R, Majster M, et al. Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clinical science. 2015; 129(3): 281–90. https://doi.org/10.1042/CS20150176 PMID: 25896238;
12. Darrieutort-Laffite C, Boutet MA, Chatelais M, Brion R, Blanchard F, Heymann D, et al. IL-1beta and TNFalpha promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblasts. Mediators of inflammation. 2014; 2014: 241840. https://doi.org/10.1155/2014/241840 PMID: 25484525;
13. Fan Q, Yan X, Zhang H, Lu L, Zhang Q, Wang F, et al. IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure. Scientific reports. 2016; 6: 39324. https://doi.org/10.1038/srep39324 PMID: 27982136.
14. Edwards JK. Acute kidney injury: IL-34 promotes persistent ischaemia-induced AKI. Nature reviews Nephrology. 2015; 11(9): 504. https://doi.org/10.1038/nrneph.2015.116 PMID: 26168739.
15. Yu G, Bing Y, Zhu S, Li W, Xia L, Li Y, et al. Activation of the interleukin-34 inflammatory pathway in response to influenza A virus infection. The American journal of the medical sciences. 2015; 349 (2): 145–50. https://doi.org/10.1097/MAJ.0000000000000373 PMID: 25415279.
16. Gerngross L, Fischer T. Evidence for cFMS signaling in HIV production by brain macrophages and microglia. Journal of neurovirology. 2015; 21(3): 249–56. https://doi.org/10.1007/s13365-014-0270-6 PMID: 25060299;
17. Preisser L, Miot C, Le Guillou-Guillemette H, Beaumont E, Foucher ED, Garo E, et al. IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology. 2014; 60(6): 1879–90. https://doi.org/10.1002/hep.27328 PMID: 25066464.
18. Ren JH, Tao Y, Zhang ZZ, Chen WX, Cai XF, Chen K, et al. Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1. Journal of virology. 2014; 88(5): 2442–51. https://doi.org/10.1128/JVI.02861-13 PMID: 24335313;
19. Lin CL, Yang HC, Kao JH. Hepatitis B virus: new therapeutic perspectives. Liver international: official journal of the International Association for the Study of the Liver. 2016; 36 Suppl 1: 85–92. https://doi.org/10.1111/liv.13003 PMID: 26725903.
20. Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases. The Journal of allergy and clinical immunology. 2016; 138(4): 984–1010. https://doi.org/10.1016/j.jaci.2016.06.033 PMID: 27577879.
21. Ivanov S, Renneson J, Fontaine J, Barthelemy A, Paget C, Fernandez EM, et al. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. Journal of virology. 2013; 87(12): 6911–24. https://doi.org/10.1128/JVI.02943-12 PMID: 23596287;
22. Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF. Protection from RNA and DNA viruses by IL-32. Journal of immunology. 2011; 186(7): 4110–8. https://doi.org/10.4049/jimmunol.1000081 PMID: 21346229.
23. Braum O, Klages M, Fickenscher H. The cationic cytokine IL-26 differentially modulates virus infection in culture. PloS one. 2013; 8(7): e70281. https://doi.org/10.1371/journal.pone.0070281 PMID: 23875025;
24. Roh EY, Song EY, Yoon JH, Oh S, Chang JY, Park H, et al. Effects of interleukin-4 and interleukin-12B gene polymorphisms on hepatitis B virus vaccination. Annals of hepatology. 2017; 16(1): 63–70. https://doi.org/10.5604/16652681.1226816 PMID: 28051794.
25. Bao S, Zheng J, Li N, Huang C, Chen M, Cheng Q, et al. Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage. Clinics and research in hepatology and gastroenterology. 2016. https://doi.org/10.1016/j.clinre.2016.10.005 PMID: 28041935.
26. Peng Y, Xiong X, Tong X, Li M, Yang X, Hu G, et al. Correlation of the content of hepatitis B core antigen in peripheral blood mononuclear cells with HBV virus load. Diagnostic microbiology and infectious disease. 2016; 85(2): 154–8. https://doi.org/10.1016/j.diagmicrobio.2015.09.017 PMID: 26680298.
27. Pollicino T, Koumbi L. Role natural killer group 2D-ligand interactions in hepatitis B infection. World journal of hepatology. 2015; 7(6): 819–24. https://doi.org/10.4254/wjh.v7.i6.819 PMID: 25937859;
28. Busca A, Kumar A. Innate immune responses in hepatitis B virus (HBV) infection. Virology journal. 2014; 11: 22. https://doi.org/10.1186/1743-422X-11-22 PMID: 24507433;
29. Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nature immunology. 2012; 13 (8): 753–60. https://doi.org/10.1038/ni.2360 PMID: 22729249;
30. Adoro S, Cubillos-Ruiz JR, Chen X, Deruaz M, Vrbanac VD, Song M, et al. IL-21 induces antiviral micro-RNA-29 in CD4 T cells to limit HIV-1 infection. Nature communications. 2015; 6: 7562. https://doi.org/10.1038/ncomms8562 PMID: 26108174;
31. Chen L, Al-Mossawi MH, Ridley A, Sekine T, Hammitzsch A, de Wit J, et al. miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. Annals of the rheumatic diseases. 2016. https://doi.org/10.1136/annrheumdis-2016-210175 PMID: 28039186.
32. Zhou SL, Hu ZQ, Zhou ZJ, Dai Z, Wang Z, Cao Y, et al. miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis. Hepatology. 2016; 63(5): 1560–75. https://doi.org/10.1002/hep.28445 PMID: 26754294.
33. Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. Journal of hepatology. 2011; 55 (5): 996–1003. https://doi.org/10.1016/j.jhep.2011.02.015 PMID: 21376091.
34. Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(47): 19975–9. https://doi.org/10.1073/pnas.0908365106 PMID: 19906987;
35. Chen R, Zhao X, Wang Y, Xie Y, Liu J. Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G. Scientific reports. 2017; 7: 40783. https://doi.org/10.1038/ srep40783 PMID: 28098260;
36. van de Klundert MA, van den Biggelaar M, Kootstra NA, Zaaijer HL. Hepatitis B Virus Protein X Induces Degradation of Talin-1. Viruses. 2016; 8(10). https://doi.org/10.3390/v8100281 PMID: 27775586;